Uncategorized

Bill Meury, president and CEO of Karuna Therapeutics, speaks with WebMD Chief Medical Officer John Whyte, MD, about the differences in drug development in psychiatry and the importance of innovation. https://www.medscape.com/viewarticle/998144?src=soc_yt — TRANSCRIPT — John Whyte, MD, MPH: Bill, thanks for joining me today. Bill Meury: Great to be here. Whyte: I want to start…

What happens when vaccine hesitancy and medical misinformation evolve into an anti-science aggression? While navigating the COVID-19 pandemic (https://www.webmd.com/covid/coronavirus), we found ourselves facing daily monumental decisions regarding our health. As the pandemic continued, many of us became well-informed about viral loads, the effectiveness of masks in preventing transmission, and the critical question of whether the…

The Food and Drug Administration is expected to decide by Dec. 8 on a new therapy to treat sickle cell disease using gene editing technology called CRISPR, which stands for clustered regularly interspaced short palindromic repeats. Approximately 250 million people worldwide carry the gene for sickle cell disease. It affects those with roots in Africa, Spanish-speaking regions…